Suppression of miRs-497/195 axis possibly confers endocrine therapy resistance via elevated expression of FLT4 and the noncoding RNA MIR503HG
S. Pramanik, P. Das, M. Mukherjee, K. V. Desai
The paper identifies miR-497/195 suppression as a mechanism of endocrine therapy resistance in breast cancer, linking it to elevated FLT4 and MIR503HG expression through RNA-seq and ceRNA network analysis.
bioRxiv · May 14, 2024 · PreprintCancer Biology